Ascentage Pharma Group International (AAPG) Invested Capital (2022 - 2025)

Ascentage Pharma Group International (AAPG) has 4 years of Invested Capital data on file, last reported at $188.2 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 409.25% year-over-year to $188.2 million; the trailing twelve-month figure through Dec 2025 stood at $188.2 million (up 409.25% YoY), and the FY2025 full-year result was $185.7 million, up 402.61% from the prior year.
• Invested Capital for Q4 2025 stood at $188.2 million, up from $37.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $188.2 million in Q4 2025 and bottomed at $13.0 million in Q4 2023.
• The 4-year median for Invested Capital is $47.2 million (2022), against an average of $73.9 million.
• The widest annual swing landed in 2023, when Invested Capital slumped 77.47%; it then jumped 409.25% in 2025.
• A 4-year view of Invested Capital shows it stood at $57.5 million in 2022, then plunged by 77.47% to $13.0 million in 2023, then jumped by 185.15% to $37.0 million in 2024, then surged by 409.25% to $188.2 million in 2025.
• The last three Invested Capital figures came in at $188.2 million (Q4 2025), $37.0 million (Q4 2024), and $13.0 million (Q4 2023), per Business Quant data.

Peer Comparison